kabutan
About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

Ranking of Decreasing Margin Buying Positions in Japan

Stock Price Apr 11, 4:00 pm JST
Margin Balance Apr 4, 2025
Total:
0
Stock
Chiome Bioscience
4583 TSE Growth
 127
+1
+0.79%
 850,800 0.00 8,160,300
-1,332,700
 8.61B High
GNI Group
2160 TSE Growth
 1,807
-28
-1.5%
 2,294,200 32.49 4,308,600
-1,329,800
 90.7B High
FRUTA FRUTA
2586 TSE Growth
 147
+5
+3.52%
 2,993,300 19,687.67 11,812,600
-1,289,300
 10.5B High
HEALIOS
4593 TSE Growth
 257
+21
+8.90%
 2,152,200 5.86 6,484,500
-1,213,200
 26B High
D.Western Therapeutics Institute
4576 TSE Growth
 110
+6
+5.77%
 969,100 0.00 6,556,300
-1,212,700
 4.98B High
Solasia Pharma
4597 TSE Growth
 32
0
ー%
 2,935,300 7.02 20,847,100
-1,146,700
 6.99B Slightly High
Modalis Therapeutics
4883 TSE Growth
 77
+1
+1.32%
 1,046,900 0.00 12,671,700
-1,111,100
 5.66B High
OncoTherapy Science
4564 TSE Growth
 24
+1
+4.35%
 3,067,400 4.13 12,348,600
-1,017,500
 6.52B Slightly High
BASE Inc
4477 TSE Growth
 389
+19
+5.14%
 4,106,100 27.22 23,333,500
-970,400
 45.3B High
RIBOMIC
4591 TSE Growth
 87
+2
+2.35%
 792,700 0.00 5,765,200
-960,400
 3.88B Slightly High
Trial Holdings
141A TSE Growth
 2,420
+180
+8.04%
 4,086,000 21.65 3,372,700
-942,600
 296B High
Perseus Proteomics
4882 TSE Growth
 422
+6
+1.44%
 929,300 0.00 2,462,100
-925,000
 6.22B High
Oncolys BioPharma
4588 TSE Growth
 527
+9
+1.74%
 609,300 0.00 3,836,100
-804,900
 13.2B High
TMS
4891 TSE Growth
 158
+8
+5.33%
 614,300 0.00 3,513,400
-786,400
 6.37B Slightly High
Astroscale Holdings
186A TSE Growth
 734
+43
+6.22%
 4,277,100 10.46 5,966,100
-731,400
 85.9B High
3-D Matrix
7777 TSE Growth
 119
+1
+0.85%
 1,391,400 0.00 6,663,700
-716,000
 13.1B Slightly High
Bushiroad
7803 TSE Growth
 534
-12
-2.2%
 773,900 19.07 1,578,700
-618,300
 38.2B Slightly High
AnGes
4563 TSE Growth
 64
+3
+4.92%
 4,662,700 24.27 35,109,800
-600,400
 20.9B Slightly High
alt Inc
260A TSE Growth
 412
-1
-0.2%
 657,500 0.00 2,982,300
-530,200
 14.5B High
ExaWizards
4259 TSE Growth
 290
+4
+1.40%
 717,400 0.00 4,312,700
-521,700
 24.9B Slightly High
About:
Liquidity
Labels